CLINICAL AND RADIOGRAPHIC OUTCOMES AFTER 3 YEARS OF SARILUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Genovese, M. [1 ]
Van Hoogstraten, H. [2 ]
Mangan, E. [3 ]
Graham, N. [3 ]
Spindler, A. [4 ]
机构：
[1] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
[2] Sanofi Genzyme, Bridgewater, MA USA
[3] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[4] Univ Nacl Tucuman, San Miguel De Tucuman, Argentina
来源：
INTERNAL MEDICINE JOURNAL | 2017年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P62
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [31] Radiographic Outcomes in Patients with Rheumatoid Arthritis Receiving Upadacitinib as Monotherapy or in Combination with Methotrexate: Results at 2 Years
    Peterfy, Charles
    Strand, Vibeke
    Genovese, Mark
    Friedman, Alan
    Enejosa, Jeffrey
    Hall, Stephen
    Mysler, Eduardo
    Durez, Patrick
    Baraliakos, Xenofon
    Shaw, Tim
    Song, Yanna
    Li, Yihan
    Song, In-Ho
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [32] RADIOGRAPHIC OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING UPADACITINIB AS MONOTHERAPY OR IN COMBINATION WITH METHOTREXATE: RESULTS AT 2 YEARS
    Hall, Stephen
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 47 - 47
  • [33] EFFICACY OF SARILUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) WHO PREVIOUSLY RECEIVED SARILUMAB OR TOCILIZUMAB
    Emery, P.
    van Hoogstraten, H.
    Jayawardena, S.
    Mangan, E. K.
    Cejas, P.
    Verschueren, P.
    INTERNAL MEDICINE JOURNAL, 2018, 48 : 21 - 21
  • [34] CLINICAL AND RADIOGRAPHIC CHARACTERISTICS OF AIRWAY DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Konda, N.
    Katsumata, Y.
    Seto, Y.
    Hasegawa, M.
    Sakai, F.
    Katsura, H.
    Yamanaka, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1359 - 1359
  • [35] Efficacy and safety of sarilumab in patients with rheumatoid arthritis stratified by age (<65 and ≥65 years): A post hoc analysis of Japanese Phase 3 clinical trials
    Tanaka, Yoshiya
    Takahashi, Toshiya
    van Hoogstraten, Hubert
    Kato, Naoto
    Kameda, Hideto
    MODERN RHEUMATOLOGY, 2024, 35 (01) : 34 - 41
  • [36] Effects of Sarilumab on Rheumatoid Arthritis as Reported by Patients Using the Rheumatoid Arthritis Impact of Disease Scale
    Gossec, Laure
    Strand, Vibeke
    Proudfoot, Clare
    Chen, Chieh-I
    Guillonneau, Sophie
    Kimura, Toshio
    van Hoogstraten, Hubert
    Mangan, Erin
    Reaney, Matthew
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (10) : 1259 - 1267
  • [37] Disease–Drug Interaction of Sarilumab and Simvastatin in Patients with Rheumatoid Arthritis
    Eun Bong Lee
    Nikki Daskalakis
    Christine Xu
    Anne Paccaly
    Barry Miller
    Roy Fleischmann
    Inga Bodrug
    Alan Kivitz
    Clinical Pharmacokinetics, 2017, 56 : 607 - 615
  • [38] ASSOCIATIONS BETWEEN RHEUMATOID ARTHRITIS DISEASE ACTIVITY AND PATIENT-REPORTED OUTCOMES IN SARILUMAB CLINICAL TRIALS
    Genovese, M. C.
    Burmester, G. R.
    Gossec, L.
    Van Hoogstraten, H.
    Praestgaard, A.
    St John, G.
    Huizinga, T.
    Aletaha, D.
    Fleischmann, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 295 - 296
  • [39] Clinical outcomes of patients with rheumatoid arthritis after switching from infliximab to etanercept
    Haraoui, B
    Keystone, EC
    Thorne, JC
    Pope, JE
    Chen, I
    Asare, CG
    Leff, JA
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (12) : 2356 - 2359
  • [40] Associations Between Rheumatoid Arthritis Disease Activity and Patient-reported Outcomes in Sarilumab Clinical Trials
    Burmester, Gerd
    Gossec, Laure
    van Hoogstraten, Hubert
    Praestgaard, Amy
    St John, Gregory
    Huizinga, Thomas
    Aletaha, Daniel
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
12345